Breadcrumbs

University of Waikato study puts Nike shoes under the spotlight

2 March 2020

Dr Kim Hébert-Losier
Dr Kim Hébert-Losier from the University of Waikato Adams Centre for High Performance.

As World Athletics clarifies the rules on shoe technology in the face of the Nike Vaporfly controversy, a new University of Waikato study cautions the Vaporfly shoe may not actually benefit all runners.

University of Waikato researchers have published a report saying the Nike Vaporfly, worn by elite athletes who have smashed world records ranging in distance from 1500 metres to marathons, may not be all they’re cracked up to be for everyone, especially when used by recreational runners.

Researchers at the university’s Adams Centre for High Performance in Tauranga in collaboration with international colleagues from The Running Clinic in Canada, put 18 male recreational runners between the age of 18 and 59 through their paces wearing three shoes: the $380 Nike Vaporfly, the runners’ own shoes and pair of Saucony Endorphin Racer 2 lightweight road racing flats.

Waikato University’s Dr Kim Hébert-Losier said while the average improvement in running economy using the Vaporfly shoes was around 4 per cent when compared to individuals own shoes, which is consistent with Nike’s branding and claims, the most interesting result showed the Vaporfly shoes could also have a negative effect on running economy in certain runners, with one runner being worse by almost 9 per cent.

She also cautions a 4 per cent improvement in running economy does not mean a 4 per cent improvement in racing times.

“Up until now, all the studies in elite athletes have only shown benefits from wearing the Vaporfly shoe and no negative responders. Our research with recreational runners showed some runners did respond negatively to the shoes.”

She said runners that were fore-foot strikers or mid-foot strikers tended to not benefit as much from the Vaporfly shoe but the team of researchers from the Adams Centre planned to explore the results further, analysing the biomechanical data collected during the trials.

The Vaporflys, first introduced in 2016, use a combination of a new lightweight foam with a high degree of energy return, called Pebax®, which is fused with a curved carbon plate to create a ‘spring’ effect that ensures less energy is lost with each step.

The shoe has caused rancour among elite competitors and rival brands. Last month, World Athletics gave its seal of approval for the Vaporfly while announcing a moratorium on any further shoe technology advancements.

“World Athletics have reformulated the rules on shoes because of the world records that are being broken by people wearing Vaporfly. It’s been called technology doping, but our research shows there is other information in the mix. These shoes don’t benefit everyone,” said Dr Hébert-Losier.

While it was hard to refute the Vaporfly shoes did work to improve the running economy of some runners, she said the lightweight racing flats also improved running economy close to 4 per cent. The racing flats weighed much less. Research has shown that for every 100 g of weight removed from a running shoe, the runner gains about a 1 per cent improvement in running economy.

“In our trials we painted all the shoes black so the runners wouldn’t be influenced by the brands and we found that of all the shoes tested, the runners’ own shoes were actually the worst of the lot.” This finding has led to the hashtag #yourshoessuck.

Since being released online in preprint form, her team’s research has been downloaded more than 350 times and received close to 40,000 impressions from Dr Hébert-Losier’s post on twitter @KimHebertLosier

“Ultimately the biggest market for Nike is the general public, not elite runners. We’re saying if you’re an elite runner sponsored by Nike, good for you if you respond favourably. But, if you’re an everyday runner running to stay fit, keep in mind that the shoes might not work for you and that the $380 spent might not be worth it.”

Twitter: https://twitter.com/KimHebertLosier/status/1222603133966110720
Preprint: https://osf.io/preprints/sportrxiv/ctavy/


Latest stories

Related stories

Dr Jason Mika

Significant funding boost for University of Waikato research

The University of Waikato has achieved significant results in the latest funding round from the…

Jo Lane

Pharmacy to add to Waikato’s health offering

The University of Waikato intends to accept its first students in a new graduate-entry Master…

Te Huataki Waiora School of Health team Dr Ryan Paul, Dr Ross Lawrenson and Dr Rawiri Keenan

Waikato bolsters health leadership team

The University of Waikato has announced three key appointments to Te Huataki Waiora School of…

Professor Chris Battershill

Renowned scientist honoured for dedication to marine conservation

World-renowned marine scientist Professor Chris Battershill has been honoured for his significant contributions to marine…

Neil Quigley and Kelvyn Eglinton

University of Waikato Medical School funding backed by Momentum Waikato

Funding for a Graduate School of Medicine at the University of Waikato will be supported…

Professor Holly Thorpe

Reimagining fields of play to grow the future of women in sport through world-class research

Waikato hosts global symposium to tackle issues from building gender-inclusive sporting environments to menstrual health…

Medical School Announcement

University of Waikato welcomes third medical school announcement

The University of Waikato welcomes the announcement by the National Party that if the Party…

Copyright Todd M. Henry 2020a

Kava based therapy for psychological trauma reaches clinical trial milestone

Waikato Pacific health researcher Dr Apo Aporosa has been awarded a Health Research Council grant…

Immunologist Dr William Kelton from the University of Waikato

Halve the herd without halving income with immune boosting milk

Imagine drinking a glass of milk to reduce your chances of picking up a nasty…

Dr Lynne Chepulis, Dr Ryan Paul

Prioritising Māori and Pacific patients for new diabetes drugs pays off

Prioritising Māori and Pacific patients in accessing two game-changing diabetes drugs is leading to better…

Assistant Vice-Chancellor Sustainability Professor Lynda Johnston

Waikato ranks in top 100 of universities globally

The University of Waikato has been recognised in the top 100 of educational institutions worldwide…

Dr Joanna Hicks

Health Research Council funding for gonorrhoea, and self-harm research

The Health Research Council of New Zealand (HRC) has announced funding for two University of…